In addition, Talin-1 can promote cancer cell adhesion, migration and invasion, and may represent a diagnostic marker of aggressive phenotypes and a potential therapeutic target for prostate cancer and OSCC [17,18]. Here, TLN1 is linked to prostate carcinoma.